Abstract
This research service covers the U.S. biotechnology: therapeutic monoclonal
antibodies market from 2004-2014. Included are a disease overviews, technology
trends, total market revenue forecasts, market segment revenue forecasts, and
market share analysis. The market is segmented by product usage: oncology,
autoimmune and inflammatory disorders, organ transplantation, cardiovascular
disorders, infectious diseases, and other indications. Major market
challenges, drivers, and restraints and identified and discussed.
| 
View Cart
